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Aims: The purpose of this study was to investigate whether heat emitted from the 
feet of patients with type 2 diabetes (DM) and peripheral arterial disease (PAD) 
differed from those with type 2 diabetes without complications (DM).  
 
Methods: A non-experimental, comparative prospective study design was 
employed in a tertiary referral hospital. Out of 223 randomly selected participants 
(430 limbs) who were initially tested, 62 limbs were categorized as DM+PAD and 
22 limbs as DM without PAD. Subjects with evidence of peripheral neuropathy 
were excluded. Participants underwent thermographic imaging. Automatic 
segmentation of Regions of Interest extracted the temperature data. 
 
Results A significant difference in temperature in all the toes between the two 
groups was found (p=0.005, p=0.033, p=0.015, p=0.038 and p=0.02 for toes 1-5 
respectively). The mean forefoot temperature in DM+PAD was significantly higher 
than that in DM (p=.019), with DM+PAD having a higher mean temperature 
(28.3oC) compared to DM (26.2oC). Similarly, the toes of subjects with DM+PAD 
were significantly warmer than those of subjects with DM only. 
 
Conclusions  Contrary to expectations the mean toe and forefoot temperatures in 
DM patients with PAD is higher than in those with DM only. This unexpected result 
could be attributed to disruption of noradrenergic vasoconstrictor 
thermoregulatory mechanisms with resulting increased flow through cutaneous 
vessels and subsequent increased heat emissivity. These results demonstrate that 
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Diabetes is a worldwide health burden which brings about many complications, 
amongst the most significant being those associated with diabetic foot disease [1]. 
One of the commonest complications is Peripheral Arterial Disease (PAD) with a 
prevalence of 3-10% in the general population increasing to 15-20% in 
individuals over 70 years of age [2]; PAD prevalence in diabetes is estimated at 
being 29% in people over 50years of age [3]. One method for diagnosing PAD in a 
clinical setting is the Ankle Brachial Pressure Index (ABPI), however it should be 
noted that the reliability of this technique has been questioned in literature, 
especially in the diabetic population presenting with arterial calcification [2]. This 
raises the need for investigating alternative methods that could possibly detect 
the presence of PAD, such as thermography, which is the infrared imaging of the 
human body. 
 
Thermography has been employed in a number of medical applications, including 
vascular disease, breast disease [4], skin disease [5] and Raynaud Phenomenon 
[6], amongst others. This technology, which is noninvasive and non-contact, has 
the potential to measure physiological changes resulting in alteration of emitted 
skin temperature [7] and skin temperature distribution [8,9]. Medical infrared 
imaging is a real-time temperature measurement technique used to produce 
visualization of thermal energy emitted by the measured site at a temperature 
above absolute zero [10] .  
 
Thermography and thermometry have been employed in the study of foot 
vascular complications and ulceration in diabetes [8,9,11–13]. Thermal changes 
  
in the plantar aspect of the diabetic foot may be the result of ischaemia, diabetic 
neuropathy, infection, or a combination of these factors (22). The neuropathic foot 
exhibits increased skin temperature indicating increased cutaneous blood flow 
[14].  
 
Temperature differences between corresponding areas on contralateral feet are 
clinically significant parameters [15]. It has been suggested that if one foot has a 
significantly higher temperature than the other, an inflammatory disease process 
may be suspected. Indeed, a temperature change >2.2oC in one foot is an indicator 
of a suspected disease process [16–18]. 
 
Van Netten et al (2013) report that whilst no difference >1.5oC was found between 
the ipsilateral and contralateral foot of participants without complications, in the 
affected Region of Interest (ROI) of patients with local complications a 
temperature of >2oC was found when compared to the similar ROI of the 
unaffected foot. Their study, however, was characterized by very small sample 
sizes of 5 participants per group [19]. 
 
In normal healthy feet, temperature patterns are symmetrical in both feet. This 
has recently been confirmed by Gatt et al who reported the thermographic 
patterns of hands and feet of healthy adults [20]. The implication is that 
asymmetry of temperature patterns between the feet may indicate the presence 
of pathology [16], which is also a logical conclusion from the findings of Gatt et al, 
who have demonstrated symmetry in the healthy adult. While this has been shown 
to be the case in the presence of peripheral neuropathy, there is a lack of studies 
  
reporting use of thermography to detect differences between healthy and 
ischaemic feet in diabetes. When both feet are ischaemic, the temperature 
difference between the two limbs may not be present, thus making detection 
utilizing this ‘asymmetry’ theory difficult. 
 
The aim of this study was to determine whether infrared thermal imaging can 
detect significant differences in the thermographic images of type 2 diabetes 




Ethical approval was sought and obtained from the University Research Ethics 
Committee. All investigations were carried out in accordance with the principles 
of the Declaration of Helsinki as revised in 2013 and all participants signed 
informed consent prior to inclusion in the study [21].  
 
Participants with type 2 diabetes were recruited from the patient list of a vascular 
surgeon at a Tertiary Referral Hospital over a 3 month period.  Participants 
underwent a thorough clinical examination that included validated tests for 
neuropathy and peripheral arterial disease. Participants with evidence of 
peripheral neuropathy were excluded for this part of the study.  Subjects with 
active ulceration or other significant co-morbidities that could affect 
thermographic patterns, such as rheumatoid arthritis and other autoimmune 
diseases, Raynaud’s Phenomenon, Charcot neuroarthrophy, venous disorders 
  
including varicose veins and deep vein thrombosis, oedema, dermatolgical and 
neurological disorders were also excluded. 
 
Prior to data collection, all participants were rested in a supine position in a room 
with temperature controlled at 23oC since ambient temperature is known to affect 
thermal emissivity of the body.  During this period, a detailed medical history was 
obtained. Following the 15-minute acclimatization period, investigations were 
carried out to detect or exclude the presence of PAD and neuropathy. The 
presence of PAD was investigated utilizing two methods: the Ankle Brachial 
Pressure Index (ABPI) and Spectral Doppler Waveform Analysis [2]. 
 
An ABPI was derived as described in literature  [2,22,23], according to standard 
clinical practice. A Huntleigh (Cardiff, Wales) Dopplex Assist was utilized for this 
purpose. PAD was diagnosed from the ABPI results, with normal values being 0.9 
-1.3. In order to include only those participants with a definite diagnosis of PAD, 
only participants with an ABPI <0.6 were included for data analysis. 
 
Spectral Doppler Waveform Analysis was also employed to classify the recorded 
Spectral Doppler waveform as being either triphasic, biphasic or monophasic [24]. 
A triphasic waveform is indicative of normal arterial perfusion, whilst the other 
two classifications are indicative of PAD, with the monophasic waveform denoting 
a more severe form of the condition. Only those participants with monophasic 




Testing for neuropathy involved the use of a 10g Semmes Weinstein 
monofilament administered on 10 sites on each foot. In this validated method, 
exactly 10g of force is applied before the monofilament bends, thus ensuring that 
exactly the same amount of force is applied. Neuropathy was diagnosed if at least 
one site was not felt by the participant. Detecting neuropathy using the 10g 
monofilament is recommended by most international guidelines including 
National Institute of Clinical Excellence (NICE), the American Diabetes Association 
(ADA) and the International Diabetes Federation (IDF)namong others. All the 
above measurements were carried out by the same experienced clinician in order 
to ensure consistency. 
 
The inclusion of participants for data analysis was determined by two experienced 
clinicians who assessed the results of the testing carried out, whilst blinded to 
each other’s results. Their decisions were later compared and a consensus 
reached between the two researchers as to whom to include in the data analysis. 
This ensured that only participants with severe PAD (ABPI<0.6 and monophasic 
waveforms) and DM subjects with no vascular and neuropathic complications 
were included in the study (Figure 1). 
 
Image acquisition, segmentation, data extraction and analysis  
A FLIR SC7200 infrared camera with a spatial resolution of 320 x 250 pixels and a 
temperature resolution of 20 mK was used for the acquisition of thermal images. 
The protocol for obtaining thermal images followed the recommendations of the 
American Academy of Thermology [10]. The camera was placed on a tripod 1.5m 
from the subject, and perpendicular to the body part that was being photographed 
  
[20].  Images of the plantar aspect of the feet and palms of the hands were 
recorded for later analysis. 
 
Thermal images obtained were segmented automatically utilizing an algorithm 
that was specifically developed for this study [25]. The feet were divided into 
regions so that temperature data could be extracted (Figure 2). 
 
Insert Figure 2 
SPSS version 24 was used to analyze data. The one-sample Kolmogorov-Smirnov 
test was used to test normality of data, which was found to be normally 
distributed. Thus a parametric test, the Independent-Sample T-Test, was the 




Out of 223 participants (430 limbs) who were initially tested and imaged, 62 limbs 
(from 9 females, mean age 64.5 yrs (sd5.9); 37 males, mean age 72.2yrs (sd8.9)) 
were categorized as DM+PAD and 22 limbs (from 7 females (mean age 59.8 
(sd11), 9 males, mean age 65.8yrs (sd7.1)) as subjects with DM. Table 1 presents 
some characteristic data of the sample population. Independent sample T-Test 
demonstrated a significant difference between all the toes of the two groups 
(p=0.005, p=0.033, p=0.015, p=0.038 and p=0.02 for toes 1-5 respectively). Higher 
mean temperatures were noted in all the toes of the DM+PAD group (Table 2) 
compared to the DM only group. 
 
  
Mean forefoot temperature in participants with DM+ PAD was also significantly 
higher than in those with DM (p=.019), (DM+PAD: 28.3oC; DM only: 26.2oC).  
Discussion 
Results of this study indicate that the regions investigated had significantly higher 
temperatures in the PAD group when compared to the non-PAD group. These 
results are unexpected since the generally held view is that in the presence of PAD 
the affected limb tends to be cooler. To ensure that the data set was homogenous 
only participants with triphasic waveforms and normal ABPIs and normal 
sensation were included in the DM group and only subjects with an ABPI below 
0.6 and monophasic waveforms and normal sensation included in the DM+PAD 
group.  This ensured that the comparison being made was between diabetes 
participants with normal perfusion (and no neuropathy) and those with 
peripheral arterial disease (and no neuropathy).  All participants with neuropathy 
were excluded as it is known that peripheral neuropathy tends to result in warmer 
feet [26]. 
The veracity of these findings is illustrated by a type 2 diabetes participant who 
presented with a warmer ischaemic right foot when compared to the normal left 
limb.  Participant had a palpable dorsalis pedis in the left foot with biphasic 
waveforms while on the right she had absent pulses, monophasic continuous 
waveforms and heel fissuring, together with rest pain. Figure 3 illustrates this 
remarkable difference as detected on thermographic imaging. 
Insert Figure 3 
 
It is standard clinical practice to palpate a patient’s limbs to detect temperature 
differences with a cooler limb normally being interpreted as possible evidence of 
  
ischaemia in that limb. The results of this study suggest that this interpretation 
may be erroneous in diabetes patients and that a cooler limb may not necessarily 
be less well perfused than the warmer one. 
 
There are several implications of the findings of this study. Firstly, in diabetes 
patients a cooler foot is not necessarily less well perfused than the contralateral 
limb.  Secondly a warm foot does not necessarily imply that the perfusion to the 
foot is normal or adequate.  This means that clinicians should not rely on clinical 
assessment of the temperature of the feet in diabetes to assess perfusion. A 
“warm” foot should not lead to the assumption that the limb is adequately 
perfused. 
  
The early diagnosis of complications associated with diabetes mellitus is a first 
prerequisite for saving the lower limb [27].  Researchers have attempted to utilize 
temperature measurement as a means of detecting diabetic foot disease, often by 
comparing the difference in temperature between the two limbs. In fact, it has 
been shown that a temperature difference >2.2oC could be indicative of diabetic 
foot disease [18].  
 
This study has identified significant temperature differences between the feet of  
type 2 diabetes participants with PAD when compared with those without  
peripheral arterial disease. This suggests that thermography may prove useful 
both as a research and clinical tool in distinguishing between diabetics with and 
without peripheral arterial disease. Baseline thermal patterns of the hands and 
feet have already been reported [20]. The next logical step would be to establish 
  
thermographic data for the various categories of diabetic feet (normal, ischaemic, 
neuropathic, neurosichaemic) to allow comparison with normative data. 
 
Although the higher temperatures in the feet of diabetes subjects with peripheral 
arterial disease is counterintuitive, one possible explanation for this is a 
disruption of normal thermoregulatory mechanisms in the feet.  It is hypothesized 
that local ischaemia may lead to disruption of sympathetically mediated 
noradrenergic vasoconstriction which leads to increased flow to the cutaneous 
vessels rather than through the deeper nutritive vessels which in turn leads to 
higher heat emissivity. Glabrous skin (soles, palms, lips) is innervated solely by 
sympathetic noradrenergic vasoconstrictor nerves while other skin is also 
innervated by sympathetic vasodilator nerves. Another important difference 
between glabrous and non glabrous skin is the existence of arteriovenous 
anastamoses (AVA) which are thick walled, low resistance conduits that allow 
high flow rates directly from arterioles to venules.  In glabrous skin, AVA are 
numerous and richly innervated by sympathetic vasoconstrictor nerves.  
Substantial changes occur in blood flow depending on whether AVAs are closed or 
open  [28]. Local ischaemia may result in failure of the sympathetically mediated 
vasoconstriction leading to increased cutaneous blood flow and therefore 
increased skin temperature. In diabetics with moderate peripheral arterial 
disease this mechanism may explain the higher foot and toe temperatures 
detected. Small changes in skin blood flow can lead to large changes in heat 
dissipation. An increase of only 8ml/100mls/min in blood flow will lead to 
doubling of heat transfer to the environment [29]. It is hypothesized that in critical 
ischaemia the perfusion to the foot is so impaired that despite vasodilatation the 
  
foot may still be cooler.  Clinically this would explain the dusky cool critically 
ischaemic foot typically referred to as the sunset foot. 
 
Since subjects were recruited from a vascular surgery clinic population, a 
potential selection bias may have been inadvertently created, although it is to be 
acknowledged that careful categorization of subjects was conducted to ensure 
that only patients with the required inclusion criteria were recruited. Another 
possible limitation could be the lack of screening for early subclinical small fibre 
autonomic neuropathy which may perhaps increase thermal emissivity in 
diabetes. The monofilament testing for protective sensation in the feet conducted 
in this study evaluated large fibre somatic nerve function.  However, there have 
been no studies to assess the impact of autonomic neuropathy on cutaneous 
temperature as measured by infrared thermography, thus implying the need for 
further research in this area. 
 
This study has revealed novel data regarding significantly higher mean 
temperature in the feet and toes of diabetics with peripheral arterial disease 
compared to those without peripheral arterial disease. 
 
Conclusion 
The feet and toes of diabetes patients with peripheral arterial disease are 
significantly warmer than those patients without peripheral arterial disease. 
These differences can easily be detected using infrared thermography which 
implies that this technology holds promise as a potential clinical tool in the 
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Tables: 
 DM+PAD DM 
Duration of 
Type 2 DM 
14.09 years 12.17 years 









Table 1: Characteristics of participants  
  
Region Mean Temp oC 
(DM+PAD) 
Mean Temp oC 
(DM) 
p-value 
Toe 1 27.85 24.81 .005 
Toe 2 27.19 24.89 .033 
Toe 3 27.18 25.07 .015 
Toe 4 27.06 26.91 .038 
Toe 5 26.98 25.07 .02 
Mean Forefoot 28.33 26.23 .019 
 
 





























43 neuroischaemic limbs (from 30 subjects), 41 neuropathic limbs (from 32 
subjects), 58 PAD limbs (from 42 subjects), 21 DM healthy limbs (15subjects,) 
 
 
Figure 1: Flow chart denoting numbers of limbs screened and excluded during the 
study process. 
 
223 DM Type 2 Participants: 430 Limbs 
 
Initial Assessment by Clinicians:  
Vascular Podiatrists/Vascular Surgeon/Nurse specialist 
 
 Participants were divided into categories: 
 
DM with no complications (no neuropathy, ABPI 1-1.3; triphasic Doppler waveforms):  
N=22 limbs from 11 subjects 
Neuropathic (10g monofilament test +ve; ABPI 1-1.3; triphasic waveforms): 41 limbs from 
32 subjects 
Neuroischaemic (10gmonofilament test +ve; ABPI<0.9; Biphasic or monophasic 
waveforms): N=43 limbs from 30 subjects 
Mild PAD (ABPI 0.9-0.7; biphasic or monophasic waveforms): 262 limbs  
Severe PAD (ABPI<0.6, monophasic waveforms): N=62 limbs from 42 subjects 
 
 
Included in the study: 
DM with no complications Group  
Severe PAD Group 
  
 




Figure 3: demonstrating remarkable difference in temperature between 
ischaemic Rt foot and a normal Lt foot with the ischaemic foot being warmer than 
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